This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Sim, E. Search for Related Content PubMed Articles by Sim, E. Social Bookmarking                         What's this?

The adduct and the addict

Genetically based N-acetyltransferase metabolic polymorphism and low-level environmental exposure to carcinogens Vineis P, Bartsch H, Caporaso N, Harrington A M, Kadlubar F F, Landi M T, Malaveille C, Sheilds P G, Skipper P, Talaska G and Tannebaum S R. Nature 1994 369, 154-156

Department of Pharmacology University of Oxford

The metabolic activation or inactivation of carcinogens varies considerably in human populations and is partly genetically determined. Inter-individual variability in the susceptibility to carcinogens may be particularly important at low degrees of environmental exposure. Examples of probable human carcinogens that present widespread low-dose exposures are environmental tobacco smoke and diesel exhaust. We have determined levels of DNA adducts in bladder cells from 39 people and of 4—aminobiphenyl-haemoglobin adducts in 97 volunteers, together with the N-acetylation non-inducible phenotype, the corresponding genotype and the levels of nicotine-cotinine in the urine. We find that amongst slow acetylators, 4—aminobiphenyl-haemoglobin adducts were higher than in rapid acetylators at low or null cotinine-nicotine levels, whereas the difference between rapid and slow acetylators was less evident at increasing nicotine-cotinine levels. The N-acetyltransferase genotype is highly predictive of the acetylation phenotype. Our results indicate that the clearance of low-dose carcinogens is decreased in the genetically based slow-acetylator phenotype. Such genetic modulation of low-dose environmental risks is relevant to 'risk assessment' procedures.

Human & Experimental Toxicology, Vol. 13, No. 8, 577-578 (1994)
DOI: 10.1177/096032719401300815


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?